| |
|
|
|
Catabasis Pharmaceuticals Inc.  
|
|
0.624 -0.018 (-0.03%) |
11-16 16:00 |
|
Open: |
0.6588 |
Pre close: |
0.6424 |
Target:
|
0.79 
|
|
High: |
0.6588 |
Low: |
0.5991 |
Resistance:
|
0.67
0.72
|
|
Volume: |
523,717 |
Market Cap: |
44M |
Support:
|
0.60
0.50
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
0.64
|
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
0.66 |
Signal(12,26,9): |
-0.02 |
|
MA(100): |
0.73 |
Stochastic Oscillator |
%K(14,3):
|
23.37 |
|
MA(250): |
1.27 |
%D(3): |
28.21 |
|
Average Volume(K) |
3-Month: |
99264
|
52-Week |
High:
|
2.38 |
|
10-Days: |
29971 |
Low: |
0.60 |
|
RSI |
RSI(14):
|
38.70 |
Change(%): |
-63.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.040 |
Return on Equity (ttm) |
-79.1 |
Shares Out. (M) |
71.04 |
|
EPS Est. Current Year |
-1.390 |
Return on Assets (ttm) |
-65.3 |
Shares Float (M) |
70.53 |
|
EPS Est. Next Year |
-1.100 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.70 |
|
EPS Est. Next Quarter |
-0.330 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
74.90 |
|
Forward EPS |
-1.190 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.090 |
EBITDA (p.s.) |
-0.096 |
P/E |
-0.60 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.57 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-25.47 |
P/S |
2216448256.00 |
|
Operating Margin |
-5157.80 |
Levered Free Cash Flow
(M) |
-14.70 |
P/CF |
-1.74 |
|
|
|
|
|
|
